Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
21 January 2000Website:
http://serinatherapeutics.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 21 Jun 2024 22:10:40 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is Serina Therapeutics?
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson's disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
What sector is Serina Therapeutics in?
Serina Therapeutics is in the Healthcare sector
What industry is Serina Therapeutics in?
Serina Therapeutics is in the Biotechnology industry
What country is Serina Therapeutics from?
Serina Therapeutics is headquartered in United States
When did Serina Therapeutics go public?
Serina Therapeutics initial public offering (IPO) was on 21 January 2000
What is Serina Therapeutics website?
https://serinatherapeutics.com
Is Serina Therapeutics in the S&P 500?
No, Serina Therapeutics is not included in the S&P 500 index
Is Serina Therapeutics in the NASDAQ 100?
No, Serina Therapeutics is not included in the NASDAQ 100 index
Is Serina Therapeutics in the Dow Jones?
No, Serina Therapeutics is not included in the Dow Jones index
When does Serina Therapeutics report earnings?
Next earnings report date is not announced yet